CA9 and cancer: To evaluate co-targeting of CAIX and other pathways relevant to cancer progression, a hybrid computational model that accounts for both tumour-immune interactions and tumour metabolism-mediated acidosis within the TME was recently developed (Grajek et al., 2023).